Quantum Cyber N.V. (QUCY) SEC filings document a Nasdaq-listed issuer whose public record includes both its former Mainz Biomed N.V. identity and its newer autonomous defense technology focus. The company’s quarterly reports and 8-K filings are important because they describe material agreements, license arrangements, property acquisition activity, capital structure matters, governance items, and operating and financial results.
For QUCY, quarterly reports can show how the company reports expenses, liabilities, share issuance, and historical operating results. Recent quarterly disclosure describes the exclusive LightShift license for quantum photonic array technology, the related accounting treatment, and the company’s issued ordinary shares. Earlier quarterly disclosure also discusses ColoAlert sales and the wind down of the prior colorectal cancer screening sales and marketing team.
Material 8-K filings are especially relevant for Quantum Cyber because they have covered the Project LightShift intellectual property license, an amendment involving BP United manufacturing and consulting services, termination of an at-the-market issuance sales agreement, a change in independent registered public accounting firm, investor presentation materials, and the Bridgeport property acquisition involving Quantum Drones Corporation and Arcade Realty LLC.
Annual reports, proxy statements, and Form 4 insider transaction reports, when available, add context on risk factors, governance, executive compensation, ownership changes, and insider trading activity. Plain-language filing summaries can help readers separate core disclosures from legal formatting, with particular attention to 10-Q reports, 10-K annual reports, Form 4 transactions, and 8-K material event filings tied to QUCY’s defense technology and manufacturing strategy.
Quantum Cyber N.V. appointed Major General (Retired) Alberto C. Rosende as a director effective October 12, 2026. He will serve until the 2027 annual general meeting or until a successor is duly elected and qualified, or his earlier death, resignation or removal. He was also appointed to the Audit, Compensation and Nomination Committees; the board determined he is independent under Nasdaq listing standards and meets the financial-literacy requirements for audit committee membership.
Rosende has been president and chief executive officer of M2i Global since September 2024 and retired from the U.S. Army in December 2021 after over 37 years of service. Peter M. O’Rourke resigned from the board and as president of wholly owned subsidiary Quantum Drones Corporation effective immediately on October 12, 2026. His employment agreement with that subsidiary, effective July 1, 2026, was terminated; the company said his board resignation was not due to a disagreement about operations, policies or practices.
Quantum Cyber N.V. (QUCY) entered into an at-the-market sales agreement allowing it to sell, from time to time, up to $100,000,000 of ordinary shares through Titan Partners Securities LLC, its sales agent. Quantum Cyber is not obligated to sell shares; the agent will use commercially reasonable efforts, subject to the agreement. Sales may occur on existing trading markets, including Nasdaq Capital Market, through market makers, or in negotiated transactions.
Quantum Cyber intends to use net proceeds, if any, for capital expenditures and software development for its motor, propeller and quantum antenna lines; operating-system software development; production capacity and product expansion, including potential acquisitions, investments or strategic partnerships or joint ventures; and working capital and general corporate purposes. The company agreed to pay the agent a commission of 3.0% of the gross sales price of shares sold, plus reimbursement of certain specified expenses.
Quantum Cyber N.V. (QUCY) may offer ordinary shares with an aggregate offering price of up to $100,000,000 through Titan Partners Securities LLC in an at-the-market offering. Titan Partners receives a 3% commission on gross sales, and the company is not required to sell shares. With prior written approval, sales may also use privately negotiated or block transactions. Intended net-proceeds uses include capital expenditures and software development, production and product expansion, potential complementary acquisitions or partnerships, working capital and general corporate purposes.
Quantum Cyber describes a strategic focus on AI- and quantum-enabled autonomous systems. It paid approximately $4.1 million for substantially all assets and the plant and land used by Arcade Metal Stamping, intending to build manufacturing capabilities at the plant.
The company says recurring operating losses raise substantial doubt about its ability to continue as a going concern. It expects to lose Form S-3 eligibility after its 2026 annual report because of an untimely required 8-K; assuming timely reports and no SEC waiver, its earliest expected return is August 1, 2027. An illustrative sale of 69,930,070 shares at an assumed $1.43 per share results in stated dilution of $0.73 per share; actual sales and prices may vary.
Quantum Cyber N.V. (QUCY), through its wholly owned subsidiary Quantum Drones Corporation, completed the acquisition of certain business assets from Arcade Technology LLC and the 38 Union Avenue property from Arcade Realty LLC on July 15, 2026. Total contractual consideration was $4,180,000 before closing prorations and QUCY’s own closing costs: $900,000 for business assets, $980,000 for inventory and $2,300,000 for the real property. The Bridgeport facility is approximately 53,000 square feet; QUCY intends to use the facility, equipment and personnel as the operational foundation for domestic autonomous defense manufacturing.
Illustrative pro forma combined results show revenue of $2,481,949 and a net loss of $16,340,620 for the six months ended June 30, 2026; pro forma total revenue for the year ended December 31, 2025 was $4,876,322, with a net loss of $16,492,185. Arcade’s historical combined statements report revenue of $4,339,242 and a net loss of $118,846 for the year ended December 31, 2025, and revenue of $2,481,949 and a net loss of $160,640 for the six months ended June 30, 2026. The pro forma figures are illustrative, not actual results or a projection; the operating statements treat the acquisition as if it occurred on January 1, 2025.
Quantum Cyber N.V. narrowed its strategic focus to three product pillars: one-way attack and interceptor drones, a quantum antenna, and the MAHCA operating system for coordinating autonomous platforms. The antenna is covered by an exclusive worldwide license with Project LightShift, Inc., dated June 11, 2026. Quantum Cyber said it has de-emphasized maritime programs and other exploratory initiatives to focus on near-term commercialization. Its four target applications are border patrol, warfare and defense UAS, law enforcement, and GPS-alternative or quantum navigation. Product descriptions are presented as design objectives rather than demonstrated performance.
Quantum Cyber completed the acquisition of its ~50,000 sq ft Bridgeport facility on July 16, 2026, and its 80-unit 3D-printing drone production farm was operational on August 31, 2026. The company targets production capacity of 100,000 drones per year, a forward-looking management projection rather than current operational capacity. Quantum Cyber describes itself as pre-revenue and says its financial statements include going-concern language.
Quantum Cyber N.V. (QUCY) reported a sharp increase in losses while executing a major strategic pivot. For the six months ended June 30, 2026, the company generated no revenue from continuing operations and recorded a net loss of $16.1 million, nearly double the prior-year period, driven by higher R&D and stock-based compensation tied to its new quantum drones and cybersecurity focus.
Total operating expenses from continuing operations rose to $12.4 million, including $4.3 million of in‑process R&D expense for a quantum antenna license from LightShift and increased general and administrative costs for new leadership and staff. The legacy colorectal cancer screening business was classified as discontinued operations and largely exited via asset sales totaling $1.6 million.
Liquidity improved: cash increased to $13.5 million from $0.9 million, mainly from $22.2 million of financing inflows, including preferred share issuances and warrant exercises. However, with an accumulated deficit of about $121.0 million and continued operating cash use of $9.9 million in the half‑year, management disclosed that these conditions raise substantial doubt about the company’s ability to continue as a going concern, and its plans depend on executing the new business model and securing further funding.
Quantum Cyber N.V. reported that Chief Financial Officer William J. Caragol received a grant of stock options on August 11, 2026. The award covers 212,500 Stock Options, each exercisable for one Ordinary Share at a conversion or exercise price of $1.37 per share and expiring on August 11, 2036. According to the grant terms, these options will vest in eighteen substantially equal monthly installments beginning on the grant date, subject to Mr. Caragol continuing to provide services through each applicable vesting date.
Quantum Cyber N.V. received a Schedule 13G indicating that BP United Inc. and Alexander Gurevich together report beneficial ownership of Ordinary Shares, nominal value (euro)0.01 per share. BP United reports beneficial ownership of 2,174,834 shares, representing 7.9% of the Ordinary Shares outstanding.
Alexander Gurevich reports beneficial ownership of 2,718,543 shares, or 9.8% of the class, including shares held through BP United. The ownership percentages are based on 27,647,833 Ordinary Shares outstanding as of July 8, 2026. The reporting persons disclaim beneficial ownership of each other’s directly held shares and state that the filing does not constitute an admission of group status.
Quantum Cyber N.V. discloses that Chief Executive Officer and ten percent owner David E. Lazar converted several classes of Preferred Shares into Ordinary Shares after stockholder approval on April 22, 2026, permitting conversion for no additional consideration at his option.
On August 5, 2026, he converted 1,000,000 Series A, 1,000,000 Series B, 1,000,000 Series C, and 124,700 Series D Preferred Shares into Ordinary Shares, leaving 875,300 Series D Preferred Shares in his direct holdings.
David E. Lazar reports updated beneficial ownership in Quantum Cyber N.V. (formerly Mainz Biomed N.V.), holding 477,000,000 Ordinary Shares, which represents 94.3% of the company’s Ordinary Shares. He has sole voting and sole dispositive power over all reported shares.
His reported holdings comprise 55,057,500 issued Ordinary Shares, 196,942,500 Ordinary Shares issuable upon conversion of Series D Preferred Shares, and 225,000,000 Ordinary Shares issuable upon conversion of Series E Preferred Shares. On August 5, 2026, he converted 1,000,000 Series A, 1,000,000 Series B, 1,000,000 Series C, and 124,700 Series D Preferred Shares into 9,000,000, 9,000,000, 9,000,000, and 28,057,500 Ordinary Shares, respectively, for no additional consideration. The ownership percentage is calculated using 84,068,192 Ordinary Shares outstanding as of August 7, 2026, plus the Series D and Series E conversion shares.